Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Diagn Virol ; 10(2-3): 151-6, 1998 Jul 15.
Article in English | MEDLINE | ID: mdl-9741640

ABSTRACT

BACKGROUND: Hepatitis C virus (HCV) NS3 proteinase activity is required for the release of HCV nonstructural proteins and is thus a potential antiviral target. The enzyme requires a protein cofactor NS4A, located downstream of NS3 on the polyprotein, for activation and efficient processing. OBJECTIVES: Comparison of the proteinase three-dimensional structure before and after NS4A binding should help to elucidate the mechanism of NS4A-dependent enzyme activation. STUDY DESIGN: We determined the crystal structure of NS3 proteinase of HCV BK isolate (genotype 1b; residues 1-189) and also the crystal structure of this proteinase complexed with HCV BK-NS4A (residues 21-34). RESULTS: The core region (residues 30-178) of the enzyme without cofactor (NS3P) or with bound cofactor (NS3P/4A) is folded into a trypsin-like conformation and the substrate P1 specificity pocket is essentially unchanged. However, the D1-E1 beta-loop shifts away from the cofactor binding site in NS3P/4A relative to NS3P, thereby accommodating NS4A. One result is that catalytic residues His-57 and Asp-81 move closer to Ser-139 and their sidechains adopt more 'traditional' (trypsin-like) orientation. The N-terminus (residues 1-30), while extended in NS3P, is folded into an alpha-helix and beta-strand that cover the bound cofactor of NS3P/4A. A new substrate-binding surface is formed from both the refolded N-terminus and NS4A, potentially affecting substrate residues immediately downstream of the cleavage site. CONCLUSIONS: Direct comparison of the crystal structures of NS3P and NS3P/4A shows that the binding of NS4A improves the anchoring and orientation of the enzyme's catalytic triad. This is consistent with the enhancement of NS3P's weak residual activity upon NS4A binding. There is also significant refolding of the enzyme's N-terminus which provides new interactions with P'-side substrate residues. The binding surface for P'-side substrate residues, including the P1 specificity pocket, changes little after NS4A binding. In summary, we observe a structural basis for improved substrate turnover and affinity that follows complexation of NS3P with its NS4A cofactor.


Subject(s)
Hepacivirus/chemistry , Hepacivirus/enzymology , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/metabolism , Binding Sites , Crystallography, X-Ray , Enzyme Activation , Humans , Models, Molecular , Protein Binding , Protein Conformation , RNA Helicases , Serine Endopeptidases/chemistry , Serine Endopeptidases/metabolism , Structure-Activity Relationship
2.
Cell ; 87(2): 331-42, 1996 Oct 18.
Article in English | MEDLINE | ID: mdl-8861916

ABSTRACT

During replication of hepatitis C virus (HCV), the final steps of polyprotein processing are performed by a viral proteinase located in the N-terminal one-third of nonstructural protein 3. The structure of NS3 proteinase from HCV BK strain was determined by X-ray crystallography at 2.4 angstrom resolution. NS3P folds as a trypsin-like proteinase with two beta barrels and a catalytic triad of His-57, Asp-81, Ser-139. The structure has a substrate-binding site consistent with the cleavage specificity of the enzyme. Novel features include a structural zinc-binding site and a long N-terminus that interacts with neighboring molecules by binding to a hydrophobic surface patch.


Subject(s)
Hepatitis C/enzymology , Viral Nonstructural Proteins/ultrastructure , Amino Acid Sequence , Binding Sites , Crystallography, X-Ray , Metalloproteins/ultrastructure , Models, Molecular , Molecular Sequence Data , Recombinant Proteins , Sequence Alignment , Trypsin , Zinc
3.
J Med Chem ; 39(9): 1872-84, 1996 Apr 26.
Article in English | MEDLINE | ID: mdl-8627611

ABSTRACT

The structure-based design and subsequent chemical synthesis of novel, urea-containing FKBP12 inhibitors are described. These compounds are shown to disrupt the cis-trans peptidylprolyl isomerase activity of FKBP12 with inhibition constants (Ki,app) approaching 0.10 microM. Analyses of several X-ray crystal structures of FKBP12-urea complexes demonstrate that the urea-containing inhibitors associate with FKBP12 in a manner that is similar to, but significantly different from, that observed for the natural product FK506.


Subject(s)
Carrier Proteins/antagonists & inhibitors , DNA-Binding Proteins/antagonists & inhibitors , Drug Design , Heat-Shock Proteins/antagonists & inhibitors , Urea/analysis , Amino Acid Isomerases/antagonists & inhibitors , Amino Acid Sequence , Carrier Proteins/chemistry , Crystallography, X-Ray , DNA-Binding Proteins/chemistry , Heat-Shock Proteins/chemistry , Humans , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Peptidylprolyl Isomerase , Structure-Activity Relationship , Tacrolimus/chemistry , Tacrolimus Binding Proteins
4.
J Med Chem ; 39(4): 904-17, 1996 Feb 16.
Article in English | MEDLINE | ID: mdl-8632414

ABSTRACT

To develop novel lipophilic thymidylate synthase (TS) inhibitors, the X-ray structure of Escherichia coli TS in ternary complex with FdUMP and the inhibitor 10-propargyl-5,8-dideazafolic acid (CB3717) was used as a basis for structure-based design. A total of 31 novel lipophilic TS inhibitors, lacking a glutamate residue, were synthesized; 26 of them had in common a N-((3,4-dihydro-2-methyl-6-quinazolinyl)methyl)-N-prop-2-ynylaniline+ ++ structure in which the aniline was appropriately substituted with simple lipophilic substituents either in position 3 or 4, or in both. Compounds were tested for their inhibition of E. coli TS and human TS and also for their inhibition of the growth in tissue culture of a murine leukemia, a human leukemia, and a thymidine kinase-deficient human adenocarcinoma. The crystal structures of five inhibitors complexed with E. coli TS were determined. Five main conclusions are drawn from this study. (i) A 3-substituent such as CF(3), iodo, or ethynyl enhances binding by up to 1 order of magnitude and in the case of CF(3) was proven to fill a nearby pocket in the enzyme. (ii) A simple strongly electron-withdrawing substituent such as NO(2) or CF(3)SO(2) in the 4-position enhances binding by 2 orders of magnitude; it is hypothesized that the transannular dipole so induced interacts favorably with the protein. (iii) Attempts to combine the enhancements of i and ii in the same molecule were generally unsuccessful (iv) A 4-C(6)H(5)SO(2) substituent provided both electron withdrawal and a van der Waal's interaction of the phenyl group with a hydrophobic surface at the mouth of the active site. The inhibition (K(is) = 12 nM) of human TS by this compound, 7n, showed that C(6)H(5)SO(2) provided virtually as much binding affinity as the CO-glutamate which it had replaced. (v) The series of compounds were poorly water soluble, and also the potent TS inhibition shown by several of them did not translate into good cytotoxicity. Compounds with large cyclic groups linked to position 4 by an SO or SO(2) group did, however, have IC(50)'s in the range 1-5 microM. Of these, 4-(N-((3,4-dihydro-2-methyl-6-quinazolinyl)methyl)-N-prop-2-ynylamino )phenyl phenyl sulfone, 7n, had IC(50)'s of about 1 microM and was chosen for further elaboration.


Subject(s)
Antineoplastic Agents/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Folic Acid Antagonists/chemical synthesis , Quinazolines/chemical synthesis , Thymidylate Synthase/antagonists & inhibitors , Adenocarcinoma , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/toxicity , Binding Sites , Cell Line , Crystallography, X-Ray , Drug Design , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Escherichia coli/enzymology , Folic Acid Antagonists/chemistry , Folic Acid Antagonists/pharmacology , Humans , Leukemia , Leukemia L1210 , Mice , Models, Molecular , Molecular Conformation , Molecular Structure , Protein Conformation , Quinazolines/chemistry , Quinazolines/pharmacology , Structure-Activity Relationship , Thymidylate Synthase/chemistry , Tumor Cells, Cultured
5.
Nature ; 378(6557): 641-4, 1995 Dec 07.
Article in English | MEDLINE | ID: mdl-8524402

ABSTRACT

Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphate which is critical for several important cellular processes, including T-cell activation. CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, respectively). We report here the crystal structures of full-length human CaN at 2.1 A resolution and of the complex of human CaN with FKBP12-FK506 at 3.5 A resolution. In the native CaN structure, an auto-inhibitory element binds at the Zn/Fe-containing active site. The metal-site geometry and active-site water structure suggest a catalytic mechanism involving nucleophilic attack on the substrate phosphate by a metal-activated water molecule. In the FKBP12-FK506-CaN complex, the auto-inhibitory element is displaced from the active site. The site of binding of FKBP12-FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein.


Subject(s)
Adaptor Proteins, Signal Transducing , Calmodulin-Binding Proteins/chemistry , Carrier Proteins/metabolism , DNA-Binding Proteins/metabolism , Heat-Shock Proteins/metabolism , Phosphoprotein Phosphatases/chemistry , Tacrolimus/metabolism , A Kinase Anchor Proteins , Amino Acid Sequence , Binding Sites , Calcineurin , Calcium/metabolism , Calmodulin-Binding Proteins/antagonists & inhibitors , Calmodulin-Binding Proteins/metabolism , Calmodulin-Binding Proteins/ultrastructure , Carrier Proteins/chemistry , Crystallization , Crystallography, X-Ray , DNA-Binding Proteins/chemistry , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Heat-Shock Proteins/chemistry , Humans , Hydrogen Bonding , Models, Molecular , Molecular Sequence Data , Phosphoprotein Phosphatases/antagonists & inhibitors , Phosphoprotein Phosphatases/metabolism , Phosphoprotein Phosphatases/ultrastructure , Protein Conformation , Protein Structure, Secondary , Proteins/metabolism , Proteins/pharmacology , Recombinant Proteins/chemistry , Tacrolimus/chemistry , Tacrolimus Binding Proteins , Water/metabolism
6.
Biochemistry ; 34(49): 15934-42, 1995 Dec 12.
Article in English | MEDLINE | ID: mdl-8519750

ABSTRACT

The crystal structure of the catalytic domain of rat DNA polymerase beta revealed that Asp256 is located in proximity to the previously identified active site residues Asp190 and Asp192. We have prepared and kinetically characterized the nucleotidyl transfer activity of wild type and several mutant forms of human and rat pol beta. Herein we report steady-state kinetic determinations of KmdTTP, Km(dT)16, and kcat for mutants in residue Asp256 and two neighboring residues, Arg254 and Arg258, all centrally located on strand beta 7 in the pol beta structure. Mutation of Asp256 to alanine abolished the enzymatic activity of pol beta. Conservative replacement with glutamic acid (D256E) led to a 320-fold reduction of kcat compared to wild type. Replacement of Arg254 with an alanine (R254A) resulted in a 50-fold reduction of kcat compared to wild type. The Km(dT)16 of D256E and R254A increased about 18-fold relative to wild type. Replacement of Arg254 with a lysine resulted in a 15-fold decrease in kcat, and a 5-fold increase in the Km(dT)16. These kinetic observations support a role of Asp256 and Arg254 in the positioning of divalent metal ions and substrates in precise geometrical orientation for efficient catalysis. The mutation of Arg258 to alanine (R258A) resulted in a 10-fold increase in KmdTTP and a 65-fold increase in Km(dT)16 but resulted in no change of kcat. These observations are discussed in the context of the three-dimensional structures of the catalytic domain of pol beta and the ternary complex of pol beta, ddCTP, and DNA.


Subject(s)
Arginine , Aspartic Acid , DNA Polymerase I/chemistry , DNA Polymerase I/metabolism , Protein Structure, Secondary , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Brain/enzymology , Cloning, Molecular , DNA Polymerase I/isolation & purification , DNA Primers , DNA, Complementary , Electrophoresis, Polyacrylamide Gel , Gene Library , Humans , Kinetics , Male , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Polymerase Chain Reaction , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Restriction Mapping , Testis/enzymology
7.
Proc Natl Acad Sci U S A ; 88(4): 1148-52, 1991 Feb 15.
Article in English | MEDLINE | ID: mdl-1705027

ABSTRACT

Two constituent protein domains of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase were expressed separately and purified to homogeneity. The N-terminal domain (p51) behaves as a monomeric protein exhibiting salt-sensitive DNA polymerase activity. The C-terminal domain (p15) on its own has no detectable RNase H activity. However, the combination of both isolated p51 and p15 in vitro leads to reconstitution of RNase H activity on a defined substrate. These results demonstrate that domains of HIV-1 reverse transcriptase are functionally interdependent to a much higher degree than in the case of reverse transcriptase from Moloney murine leukemia virus.


Subject(s)
Endoribonucleases/metabolism , HIV-1/genetics , RNA-Directed DNA Polymerase/metabolism , Base Sequence , Cloning, Molecular , Endoribonucleases/genetics , Escherichia coli/genetics , HIV-1/enzymology , Humans , Molecular Sequence Data , Plasmids , RNA-Directed DNA Polymerase/genetics , RNA-Directed DNA Polymerase/isolation & purification , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Restriction Mapping , Ribonuclease H , Substrate Specificity , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/isolation & purification , Tetrahydrofolate Dehydrogenase/metabolism
8.
Nucleic Acids Res ; 14(15): 6115-28, 1986 Aug 11.
Article in English | MEDLINE | ID: mdl-3748805

ABSTRACT

Short synthetic oligonucleotides have been covalently cross-linked to alkaline phosphatase using the homobifunctional reagent disuccinimidyl suberate. The oligomers, twenty-one to twenty-six bases in length, are complementary to unique sequences found in herpes simplex virus, hepatitis B virus, Campylobacter jejuni and enterotoxigenic Escherichia coli. Each oligomer contains a single modified base with a 12-atom "linker arm" terminating in a reactive primary amine. Cross-linking through this amine results in oligomer-enzyme conjugates composed of one oligomer per enzyme molecule that have full alkaline phosphatase activity and can hybridize to target DNA fixed to nitrocellulose within 15 minutes. The hybrids are detected directly with a dye precipitation assay at a sensitivity of 10(6) molecules (2 X 10(-18) mol) of target DNA in 4 hours development time. The enzyme has no apparent effect on selectivity or kinetics of oligonucleotide hybridization and the conjugates can be hybridized and melted off in a conventional manner.


Subject(s)
Nucleic Acid Hybridization , Oligodeoxyribonucleotides/metabolism , Alkaline Phosphatase/metabolism , Base Sequence , Cross-Linking Reagents , Methods , Oligodeoxyribonucleotides/chemical synthesis , Protein Binding , Succinimides
SELECTION OF CITATIONS
SEARCH DETAIL
...